Esophageal Fistula Clinical Trial
Official title:
Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment in the Management of Benign Esophageal Pathology: A Randomized Controlled Trial
Esophageal stents are commonly used for benign esophageal pathology, especially strictures or esophageal mucosal defects such as leaks, fistulae, or perforations. The major limiting factor to stent placement is the high migration rate of the stent. Investigators are trying to prospectively evaluate the efficacy of endostitch in preventing stent migration in benign esophageal disease in comparison with standard, fully covered self-expanding metal stents (FCSEMS) placement without fixation.
The use of removable, fully covered self-expanding metal stents (FCSEMS) in the management
of benign esophageal pathology has been increasingly applied in recent years. Several
studies have shown promising results with its application in esophageal perforation,
fistula, or leak, and refractory benign strictures. However, the major limiting factor to
successful treatment with FCSEMS in this setting is the substantial migration rates.
Different strategies has been used to secure esophageal stents but to little success.
Several tertiary institutions including investigators have adopted the use of endostitch
(ES) with the OverStitchTM system (Apollo Endosurgery, Austin, Texas) as the preferred
method for stent fixation. Animal ex-vivo studies have confirmed the greater anchoring
ability and tensile strength with this method when compared to esophageal stenting alone or
with through the endoscope clip fixation while retrospective series have shown promising
results with lower rates of stent migration when compared to conventional stent insertion.
However, although the use of endostitch stent fixation has been used in several centers in
the United-States with strong retrospective data (including investigators data), no
prospective randomized controlled trial have confirmed its effectiveness in preventing stent
migration.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01900691 -
Removal of the Evolution® Esophageal Stent - Fully Covered
|
N/A | |
Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
Recruiting |
NCT04571541 -
Endoscopic Management of Esophageal Wall Defects
|
||
Recruiting |
NCT05758805 -
Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF (ESO-SAFE-HP-RF)
|
N/A | |
Not yet recruiting |
NCT02665442 -
Retracting the Esophagus During AF Ablation
|
N/A |